This study investigated the association between ischaemia-modified albumin (IMA), a biomarker of cardiac ischaemia, and increases in the levels of intermediatedensity lipoprotein (IDL), an atherogenic particle that can cause oxidative stress, in haemodialysis patients with end-stage renal disease (ESRD). Fasting levels of serum IMA and lipids/lipoproteins were analysed in 15 patients and 15 healthy control subjects. There was a close positive correlation between IMA and IDL levels in ESRD patients but no significant correlation between IMA and lipids/lipoproteins in control subjects. This suggests a possible link between the characteristic dyslipoproteinaemia found in ESRD and levels of IMA and, if confirmed in studies with larger sample sizes, may lead to further studies on the potential of the relationship between IMA and IDL as a biomarker in haemodialysis patients with ESRD.
Introduction
End-stage renal disease (ESRD) is associated with an increased incidence of atherosclerosis, which can lead to cardiovascular disease (CVD). 1, 2 Several underlying mechanisms are involved in the increased incidence of atherosclerosis, including abnormal lipid/lipoprotein metabolism. 1, 2 Although levels of plasma or serum total cholesterol (TC) and/or lowdensity lipoprotein cholesterol (LDL-C) are rarely elevated, intermediate-density lipoprotein (IDL) is an independent risk factor for CVD in ESRD patients. 1, 2 This suggests that the uraemic milieu could enhance the atherogenic nature of remnant lipoproteins, such as IDL, in these patients. 1, 2 Ischaemia-modified albumin (IMA) is a new biomarker of CVD. Under conditions of tissue ischaemia, for example in coronary artery disease, the NH 2 terminus of human serum albumin is structurally modified, affecting its binding affinity to cobalt that could serve as a diagnostic test for K Kotani, S Kimura, E Kinugasa et al.
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ischaemia. 3 It has been reported that increased levels of IMA can predict mortality (mostly from cardiac disorders) in ESRD patients. 4 There is evidence of modification of albumin by both acute and chronic oxidative stress (e.g. in diabetes and hyperlipidaemia). 5, 6 The IDLs also have atherogenic properties that can lead to oxidative/ischaemic conditions. 7 The present study was intended as a preliminarily examination of the association between IMA and IDL levels in haemodialysis patients with ESRD, which has not been characterized previously.
Patients and methods

STUDY DESIGN AND PARTICIPANTS
This study was conducted between April and December 2009 in randomly selected ESRD patients referred to Showa University Northern Yokohama Hospital (Yokohama, Japan), who were undergoing maintenance haemodialysis (a mean course of 7 years), and in healthy age-and gender-matched controls recruited during health check-ups in that hospital. All patients underwent dialysis three times a week on a non-reprocessed synthetic polysulphone dialyser (Asahi Kasei Kuraray Medical Co. Ltd, Tokyo, Japan). All enrolled patients were non-smokers who did not have acute illness. Patients with a history of CVD, thyroid disorder, cancer or liver abnormalities were excluded.
The study protocol was approved by the Ethics Committee of Showa University and written informed consent was obtained from all participants.
BIOCHEMICAL MEASUREMENTS
After an overnight fast, blood was sampled by venipuncture before dialysis. Dry tubes, containing sodium citrate (5 mmol/l final concentration) as an anticoagulant, were used to collect serum. Blood was centrifuged at 1600 g at 4°C for 7 min and separated serum was analysed immediately or frozen at −80°C until analyses for IMA. Levels of serum TC, high-density lipoprotein cholesterol (HDL-C) and triglycerides (TG) were measured enzymatically (Sekisui Co. Ltd, Tokyo, Japan) using an automatic Hitachi-7600 analyser system (Hitachi Co. Ltd, Tokyo, Japan) according to the manufacturer's instructions. Lipoprotein subfractions were analysed by disc electrophoresis (LipoPhor ® electrophoretic system; Quantimetrix Corp., Redondo Beach, CA, USA) according to the manufacturer's instructions. Briefly, serum samples (25 µl) were added to 200 µl of loading gel solution containing Sudan Black B, photo polymerized for 30 min and electrophoresed on a 3% polyacrylamide gel for 25 min. The gel was scanned with a densitometer and the percentages for subfractional lipoproteins were calculated.
The level of serum IMA was assessed by measuring the decrease in cobalt binding, according to previously published methods, 3, 8 and the results were expressed as absorbance units; the intra-assay coefficient of variation was 5.0% at a mean of 0.51 absorbance units.
STATISTICAL ANALYSES
Data were expressed as mean ± SD or median plus interquartile range. All analyses were performed using the SPSS ® statistical package, version 16.0 (SPSS Inc., Chicago, IL, USA) for Windows ® . Differences between ESRD patients and controls were compared using an unpaired t-test. Correlations between serum IMA and the other variables were analysed using Pearson's correlation coefficient and partial correlation coefficient adjusted for age, gender and body mass index (BMI). Skewed variables were logtransformed. A P-value ≤ 0.05 was considered to be statistically significant.
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Results
A total of 15 ESRD patients (seven men and eight women, mean ± SD age 60 ± 9 years, BMI 22 ± 4 kg/m 2 ) and 15 age-and gendermatched healthy control subjects (seven men and eight women; mean ± SD age 59 ± 9 years; mean ± SD BMI 21 ± 2 kg/m 2 ) were evaluated. Table 1 shows the levels of the lipid/ lipoprotein parameters between the two groups. The ESRD patients exhibited higher levels of IMA (P = 0.05), TG (P < 0.01) and LDL subfraction (P < 0.01) than control subjects.
In univariate analyses, IMA was significantly and positively correlated with the IDL subfraction (r = 0.596; P = 0.019) but not with other variables in ESRD patients ( Table 2) . Partial correlation coefficient adjusted for age, gender and BMI revealed a significant positive correlation between IMA and IDL in these patients (r = 0.556; P = 0.03). There was no significant correlation between IMA and lipids/lipoproteins in control subjects.
Discussion
The present study demonstrated a statistically significant correlation between IDL and IMA levels among haemodialysis patients with ESRD. As in a previous study, 8 the present study also showed a higher concentration of IMA in patients with ESRD than in healthy control subjects. The previous study had demonstrated that IMA levels were unchanged after haemodialysis, suggesting that IMA may not be greatly affected by renal filtration. 8 Because IDL is a key component of the atherogenic dyslipoproteinaemia that is associated with ESRD 1,2 and because IMA is of prognostic benefit for cardiac mortality in ESRD, 4 the present finding of the relationship between IDL and IMA in patients with ESRD is noteworthy, particularly considering the apparent lack of correlation between IMA and the other lipids/lipoproteins in ESRD patients and the lack of significant correlation between levels of IMA and IDL in control subjects. The progression of atherosclerosis with oxidative stress related to IDL 1,2,7 may mechanistically lead to protein oxidation, as shown in the formation of IMA, even in subclinical CVD states. The There were some limitations to the present study. Anaemia, impaired iron metabolism and low albumin levels are common and can be associated with hyperoxidative stress in ESRD patients. 9 -12 In particular, anaemia, which is related to mild hypoxia owing to low haemoglobin levels, has been reported as a possible contributory factor to increased IMA levels in haemodialysis patients. 12 It may be that the ESRD patients were more anaemic than the healthy controls so, to provide a plausible explanation of the relationship between IDL and IMA, additional studies on the influence of various ESRD-related biomarkers on IMA are required.
TABLE 1: Comparison of lipid/lipoprotein parameters between patients with end-stage renal disease (ESRD) and control subjects
Controls
In summary, the present study demonstrated a statistically significant positive correlation between IDL and IMA levels in haemodialysis patients with ESRD. Although this is a preliminary study, it suggests a possible link between the characteristic dyslipoproteinaemia found in ESRD and IMA and, if confirmed in studies with larger sample sizes, may lead to further work on pathogenic mechanisms and the potential of the relationship between IDL and IMA as a biomarker in haemodialysis patients with ESRD.
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